Pharmaceutical

Clinical exclusivity for indigenous medicines can impro...

Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clin...

Morepen Laboratories clears fourth USFDA inspection at ...

Outcome follows Rs 825 crore CDMO mandate and supports global manufacturing eng...

Rusan Pharma secures PMDA GMP approval for Ankleshwar a...

Approval from Japan regulator covers API and finished dosage manufacturing unit...

Aligos and Xiamen Amoytop sign deal for HBV therapy

This territory includes Hong Kong, Macau, Mainland China, and Taiwan. The focus ...

Daiichi Sankyo and Interna partner for MNM-targeted del...

The agreement involves Daiichi Sankyo Research Institute Boston and aims to asse...

Lupin subsidiary enters settlement agreement with Human...

Lupin Pharmaceuticals Inc to pay USD 30 million under agreement without admissi...

Aurobindo Pharma secures USFDA approval for Glycerol Ph...

Company to launch product for urea cycle disorders with market size of US$ 50....

Nucleai and Sirona Dx to provide new proteomics solutio...

The collaboration aims to bridge gaps between data generation and actionable ins...

Alembic Pharma gets USFDA nod for Methotrexate Injectio...

Methotrexate Injection is a folate analog metabolic inhibitor indicated for neo...

Boehringer Ingelheim and Zai Lab team up for dual DLL3 ...

This Phase Ib/II study will measure the tolerability, safety, and early clinical...

Rubicon Research acquires 85% stake in Arinna Lifesciences

Transaction valued at INR 200 crore to expand presence in CNS therapies and dom...

Adcendo secures $75m in Series C funding for ADC develo...

The financing will support Adcendo’s ongoing advancement of its first-in-class a...

Lilly to acquire CrossBridge Bio for up to $300m

The acquisition includes the lead candidate CBB-120, a dual-payload antibody-dru...

MSN Laboratories launches SEMABEST semaglutide in India...

Product priced lower than innovator drug and introduced for type 2 diabetes tre...

Aurigene and Alveus Therapeutics advance collaboration ...

Partnership supports drug discovery programmes for obesity and metabolic diseas...

Orbicular, Gland Pharma and Apotex secure US FDA approv...

ANDA approval with CGT designation grants six-month exclusivity for parenteral ...